Comerica Bank Charles River Laboratories International, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Comerica Bank holds 16,476 shares of CRL stock, worth $3.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

16,476

Previous 17,147 3.91%

Holding current value

$3.23 Million

Previous $3.54 Million 8.39%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $126,121 - $164,589	-671 Reduced 3.91%	16,476 $3.25 Million
Q2 2024 Aug 15, 2024	SELL	$206.39 - $268.73 $75,745 - $98,623	-367 Reduced 2.1%	17,147 $3.54 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $188,663 - $253,469	927 Added 5.59%	17,514 $4.75 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $161,558 - $234,540	-982 Reduced 5.59%	16,587 $3.92 Million
Q3 2023 Nov 21, 2023	SELL	$194.44 - $217.61 $1.17 Million - $1.31 Million	-6,008 Reduced 25.48%	17,569 $3.44 Million
Q2 2023 Aug 22, 2023	BUY	$183.71 - $210.25 $3.13 Million - $3.58 Million	17,051 Added 261.28%	23,577 $24,000
Q4 2022 Jan 26, 2023	SELL	$197.11 - $250.07 $394,220 - $500,140	-2,000 Reduced 23.46%	6,526 $0
Q3 2022 Oct 28, 2022	BUY	$182.44 - $250.54 $12,588 - $17,287	69 Added 0.82%	8,526 $1.71 Million
Q2 2022 Aug 02, 2022	BUY	$204.13 - $302.4 $20,208 - $29,937	99 Added 1.18%	8,457 $1.91 Million
Q1 2022 Apr 27, 2022	SELL	$255.51 - $362.11 $17,119 - $24,261	-67 Reduced 0.8%	8,358 $2.37 Million
Q4 2021 Feb 18, 2022	SELL	$351.38 - $448.68 $16,866 - $21,536	-48 Reduced 0.57%	8,425 $3.17 Million
Q3 2021 Nov 22, 2021	SELL	$372.64 - $458.3 $935,699 - $1.15 Million	-2,511 Reduced 22.86%	8,473 $3.5 Million
Q2 2021 Aug 26, 2021	SELL	$294.17 - $371.65 $13.8 Million - $17.4 Million	-46,934 Reduced 81.04%	10,984 $4.06 Million
Q1 2021 Apr 28, 2021	BUY	$249.67 - $299.48 $1.29 Million - $1.55 Million	5,177 Added 9.82%	57,918 $16.8 Million
Q4 2020 Jan 28, 2021	BUY	$222.0 - $252.62 $2.85 Million - $3.25 Million	12,856 Added 32.23%	52,741 $13.2 Million
Q3 2020 Oct 30, 2020	BUY	$175.56 - $226.45 $257,722 - $332,428	1,468 Added 3.82%	39,885 $9.03 Million
Q2 2020 Jul 31, 2020	BUY	$118.84 - $189.72 $357,708 - $571,057	3,010 Added 8.5%	38,417 $6.7 Million
Q1 2020 May 01, 2020	SELL	$98.9 - $178.34 $81,889 - $147,665	-828 Reduced 2.29%	35,407 $4.47 Million
Q4 2019 Feb 07, 2020	BUY	$126.05 - $152.76 $16,638 - $20,164	132 Added 0.37%	36,235 $5.54 Million
Q3 2019 Oct 31, 2019	BUY	$125.07 - $143.67 $144,580 - $166,082	1,156 Added 3.31%	36,103 $4.78 Million
Q2 2019 Aug 02, 2019	SELL	$123.4 - $148.55 $515,565 - $620,641	-4,178 Reduced 10.68%	34,947 $0
Q1 2019 May 02, 2019	SELL	$104.82 - $146.73 $73,793 - $103,297	-704 Reduced 1.77%	39,125 $0
Q4 2018 Feb 06, 2019	BUY	$105.09 - $137.23 $937,297 - $1.22 Million	8,919 Added 28.85%	39,829 $4.76 Million
Q3 2018 Nov 01, 2018	SELL	$112.11 - $134.54 $630,955 - $757,191	-5,628 Reduced 15.4%	30,910 $3.76 Million
Q2 2018 Aug 01, 2018	SELL	$102.37 - $117.25 $87,935 - $100,717	-859 Reduced 2.3%	36,538 $4.38 Million
Q1 2018 May 01, 2018	SELL	$98.19 - $115.2 $11,390 - $13,363	-116 Reduced 0.31%	37,397 $3.96 Million
Q4 2017 Feb 02, 2018	BUY	$100.43 - $118.09 $10,143 - $11,927	101 Added 0.27%	37,513 $3.96 Million
Q3 2017 Nov 06, 2017	BUY	$96.72 - $109.26 $3.62 Million - $4.09 Million	37,412	37,412 $4.31 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account